Information Library

Results for: Business transformation - Connect with investigators, regulators and physicians

To learn more about Quintiles’ services, you may broaden or narrow your search by selecting the topics at left.

Start Over

  • Sort by:
  • Recently Added
  • Title

  • Quintiles Agrees to Acquire Premier GLP Bioanalytics Laboratory

    Press Release — October 26, 2011 – To provide a more comprehensive and efficient global solution for its laboratory customers, Quintiles signed of a definitive agreement to acquire Advion BioServices.

  • Hybrid Sales Solutions

    Hear from the Experts — April 19, 2011
    Joseph Chirillo, Senior Vice President, Commercialization, Strategic and Risk-Based Business, discusses the different challenges of reaching physicians in densely and sparsely populated areas.

  • Clinical – Smarter Trials, Accelerated Outcomes

    Brochure — February 16, 2011
    Quintiles will work with you to plan and execute the smartest clinical trials and post-marketing studies, informed by a holistic view of strategic, operational, regulatory and marketplace issues.

  • Using Real-Time Data to Drive Better Decisions, Faster

    White Paper — September 30, 2010
    This white paper examines the advantages afforded by access to real-time data during the course of a clinical trial.

  • THE NEW HEALTH REPORT FINDS GREATER INFLUENCE FOR PATIENTS ON DRUG DEVELOPMENT

    Press Release — June 15, 2010 - Patients are emerging as an increasingly strong group when it comes to influencing the success and failure of new drugs – according to a newly published New Health Report commissioned by Quintiles.

  • Commercial – Identify, Promote and Prove Treatment Value

    Brochure — April 1, 2010
    Quintiles has built an unmatched suite of commercial competencies that biopharma companies are leveraging for faster market access and sustained success.

  • Medicare Part D’s Effect On Prescribing Volume

    Presentation — June 25, 2009
    Poster presented during the ISPOR 14th Annual International Meeting 2009 (International Society for Pharmacoeconomics and Outcomes Research) titled “Medicare Part D’s Effect On Prescribing Volume: Average Monthly Utilization of Selected High Use Drugs In The Six Protected Classes, By Different Specialties.”

Page 1 of 1 (7 results)

Subscribe to Email Based on Your Interests

Set preferences